HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hideyoshi Higashi Selected Research

trisialoganglioside GT1

5/2012Involvement of ganglioside GT1b in glutamate release from neuroblastoma cells.
2/2011Intraplantar injection of gangliosides produces nociceptive behavior and hyperalgesia via a glutamate signaling mechanism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hideyoshi Higashi Research Topics

Disease

2Inflammation (Inflammations)
10/2021 - 08/2015
2Neuroblastoma
05/2012 - 04/2012
1Neoplasms (Cancer)
10/2021
1Pain (Aches)
08/2015
1Hyperalgesia
02/2011

Drug/Important Bio-Agent (IBA)

2trisialoganglioside GT1IBA
05/2012 - 02/2011
2Glutamic Acid (Glutamate)FDA Link
05/2012 - 02/2011
1Adrenergic Receptors (Adrenergic Receptor)IBA
10/2021
1CatecholaminesIBA
10/2021
1Hyaluronic Acid (Hyaluronan)IBA
10/2021
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
08/2015
1uridine triphosphate receptorsIBA
08/2015
1Adenosine Triphosphate (ATP)IBA
08/2015
1BradykininIBA
08/2015
1Culture MediaIBA
05/2012
1polysialic acidIBA
04/2012
1N-Methylaspartate (NMDA)IBA
02/2011
1Glutamate Receptors (Glutamate Receptor)IBA
02/2011
1Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA
02/2011
1Glutamate DehydrogenaseIBA
02/2011
1GangliosidesIBA
02/2011